SCHEDULE 13D

Company

Aptose Biosciences Inc.

Filed

September 12, 2023

Accession Number

0001213900-23-075818

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →